<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hesse C</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>11133</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11508481</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(20)</volume><pubmed_abstract>Tegaserod (1-{[(5-methoxy-1H-indol-3-yl)methyliden]amino}-3-pentylguanidine) is a potent agonist at human recombinant 5-HT&lt;sub>4&lt;/sub> serotonin receptors. Consequently, tegaserod is utilized in the treatment of bowel diseases. The objective of this study was to test the hypothesis that tegaserod stimulates human cardiac atrial 5-HT&lt;sub>4&lt;/sub>-receptors via cyclic adenosine monophosphate (cAMP)-dependent pathways. Tegaserod exerted positive inotropic effects (PIEs) and positive chronotropic effects (PCEs) in isolated left and right atrial preparations, respectively, from mice with cardiac-specific overexpression of the human 5-HT&lt;sub>4&lt;/sub> serotonin receptor (5-HT&lt;sub>4&lt;/sub>-TG) in a concentration- and time-dependent manner. However, no effect was observed in the hearts of littermates </pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Tegaserod Stimulates 5-HT&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt; Serotonin Receptors in the Isolated Human Atrium.</pubmed_title><pmcid>PMC11508481</pmcid><funding_grant_id>PO732</funding_grant_id><pubmed_authors>Muller FE</pubmed_authors><pubmed_authors>Neumann J</pubmed_authors><pubmed_authors>Compan V</pubmed_authors><pubmed_authors>Ponimaskin E</pubmed_authors><pubmed_authors>Hofmann B</pubmed_authors><pubmed_authors>Hesse C</pubmed_authors><pubmed_authors>Gergs U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tegaserod Stimulates 5-HT&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt; Serotonin Receptors in the Isolated Human Atrium.</name><description>Tegaserod (1-{[(5-methoxy-1H-indol-3-yl)methyliden]amino}-3-pentylguanidine) is a potent agonist at human recombinant 5-HT&lt;sub>4&lt;/sub> serotonin receptors. Consequently, tegaserod is utilized in the treatment of bowel diseases. The objective of this study was to test the hypothesis that tegaserod stimulates human cardiac atrial 5-HT&lt;sub>4&lt;/sub>-receptors via cyclic adenosine monophosphate (cAMP)-dependent pathways. Tegaserod exerted positive inotropic effects (PIEs) and positive chronotropic effects (PCEs) in isolated left and right atrial preparations, respectively, from mice with cardiac-specific overexpression of the human 5-HT&lt;sub>4&lt;/sub> serotonin receptor (5-HT&lt;sub>4&lt;/sub>-TG) in a concentration- and time-dependent manner. However, no effect was observed in the hearts of littermates </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-26T00:12:55.475Z</modification><creation>2025-04-06T09:42:29.914Z</creation></dates><accession>S-EPMC11508481</accession><cross_references><pubmed>39456915</pubmed><doi>10.3390/ijms252011133</doi></cross_references></HashMap>